2024 Q2 Form 10-Q Financial Statement

#000095017024052191 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $4.045M $4.031M
YoY Change -7.22% -12.04%
Cost Of Revenue $1.690M $1.743M
YoY Change -46.75% -46.2%
Gross Profit $2.355M $2.288M
YoY Change 98.57% 70.36%
Gross Profit Margin 58.22% 56.76%
Selling, General & Admin $2.643M $2.934M
YoY Change -39.62% -32.72%
% of Gross Profit 112.23% 128.23%
Research & Development $1.799M $1.881M
YoY Change -35.68% -36.06%
% of Gross Profit 76.39% 82.21%
Depreciation & Amortization $2.000K $2.000K
YoY Change -99.53% -99.53%
% of Gross Profit 0.08% 0.09%
Operating Expenses $4.442M $4.815M
YoY Change -38.08% -34.07%
Operating Profit -$2.087M -$2.527M
YoY Change -65.15% -57.6%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $138.0K $104.0K
YoY Change -35.81% -53.78%
Pretax Income -$1.949M -$2.423M
YoY Change -66.24% -57.75%
Income Tax $69.00K -$12.00K
% Of Pretax Income
Net Earnings -$2.018M -$2.411M
YoY Change -65.89% -58.31%
Net Earnings / Revenue -49.89% -59.81%
Basic Earnings Per Share -$0.65 -$0.80
Diluted Earnings Per Share -$0.65 -$0.80
COMMON SHARES
Basic Shares Outstanding 3.106M 18.07M
Diluted Shares Outstanding 3.108M 3.024M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.942M $9.563M
YoY Change -58.15% -59.68%
Cash & Equivalents $7.942M $9.563M
Short-Term Investments
Other Short-Term Assets $1.087M $1.386M
YoY Change -20.25% -16.15%
Inventory
Prepaid Expenses
Receivables $3.551M $3.422M
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.58M $14.37M
YoY Change -48.3% -51.16%
LONG-TERM ASSETS
Property, Plant & Equipment $116.0K $118.0K
YoY Change -96.77% -96.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $517.0K $504.0K
YoY Change 0.98% -11.11%
Total Long-Term Assets $1.852M $2.235M
YoY Change -72.51% -70.48%
TOTAL ASSETS
Total Short-Term Assets $12.58M $14.37M
Total Long-Term Assets $1.852M $2.235M
Total Assets $14.43M $16.61M
YoY Change -53.55% -55.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $585.0K $609.0K
YoY Change -34.34% -49.59%
Accrued Expenses $294.0K $236.0K
YoY Change -66.4% -60.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.600M $4.042M
YoY Change -36.1% -34.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $973.0K $980.0K
YoY Change -4.14% -3.64%
Total Long-Term Liabilities $973.0K $980.0K
YoY Change -4.14% -3.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.600M $4.042M
Total Long-Term Liabilities $973.0K $980.0K
Total Liabilities $4.573M $5.022M
YoY Change -41.47% -44.26%
SHAREHOLDERS EQUITY
Retained Earnings -$348.7M -$346.7M
YoY Change 4.38% 5.65%
Common Stock $359.5M $359.2M
YoY Change 0.35% 0.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.859M $11.58M
YoY Change
Total Liabilities & Shareholders Equity $14.43M $16.61M
YoY Change -53.55% -55.11%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$2.018M -$2.411M
YoY Change -65.89% -58.31%
Depreciation, Depletion And Amortization $2.000K $2.000K
YoY Change -99.53% -99.53%
Cash From Operating Activities -$1.576M -$1.729M
YoY Change -61.1% -53.17%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -37.00K -60.00K
YoY Change -60.64% -850.0%
NET CHANGE
Cash From Operating Activities -1.576M -1.729M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -37.00K -60.00K
Net Change In Cash -1.613M -1.800M
YoY Change -65.85% -57.56%
FREE CASH FLOW
Cash From Operating Activities -$1.576M -$1.729M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$1.576M -$1.729M
YoY Change -65.95% -53.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001389002
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-35838
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Marin Software Incorporated
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4647180
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
149 New Montgomery Street
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
CY2024Q1 dei City Area Code
CityAreaCode
415
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
399-2580
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
CY2024Q1 dei Trading Symbol
TradingSymbol
MRIN
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3106361
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9563000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11363000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3422000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3864000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1386000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1548000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
14371000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
16775000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1613000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1912000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
504000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
508000
CY2024Q1 us-gaap Assets
Assets
16606000
CY2023Q4 us-gaap Assets
Assets
19315000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
609000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
664000
CY2024Q1 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1820000
CY2023Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2099000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1613000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1518000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4042000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4281000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
394000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
980000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1001000
CY2024Q1 us-gaap Liabilities
Liabilities
5022000
CY2023Q4 us-gaap Liabilities
Liabilities
5676000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47619000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47619000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3061000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3061000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3011000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3011000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
359234000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
358884000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-346662000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-344251000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-991000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-997000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
11584000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13639000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16606000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19315000
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4031000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4583000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1743000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3240000
CY2024Q1 us-gaap Gross Profit
GrossProfit
2288000
CY2023Q1 us-gaap Gross Profit
GrossProfit
1343000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1250000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2025000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1881000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2942000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1684000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2336000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
4815000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
7303000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2527000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5960000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
104000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
225000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2423000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5735000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2411000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5783000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2405000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5788000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.8
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.8
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3024000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3024000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2873000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2873000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13639000
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
63000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
413000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2411000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
11584000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
32714000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1069000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5783000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27985000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2411000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5783000
CY2024Q1 us-gaap Depreciation
Depreciation
2000
CY2023Q1 us-gaap Depreciation
Depreciation
11000
CY2024Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
419000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
371000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
399000
CY2024Q1 mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
87000
CY2023Q1 mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
94000
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-4000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
413000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1032000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-10000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-279000
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-459000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-734000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-81000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-232000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-55000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
194000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-297000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-350000
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-371000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-399000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1729000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3692000
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
579000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-579000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
60000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10000
CY2024Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
18000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
501000
CY2024Q1 mrin Provision For Doubtful Accounts Reductions To Expense
ProvisionForDoubtfulAccountsReductionsToExpense
10000
CY2024Q1 mrin Allowance For Doubtful Accounts Receivable Write Offs And Other Deductions
AllowanceForDoubtfulAccountsReceivableWriteOffsAndOtherDeductions
70000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
421000
CY2024Q1 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
13000
CY2023Q4 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
12000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-11000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1800000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4241000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11363000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27957000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9563000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23716000
CY2024Q1 mrin Reverse Stock Split And Reduction In Authorized Shares Policytext Block
ReverseStockSplitAndReductionInAuthorizedSharesPolicytextBlock
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reverse Stock Split and Reduction in Authorized Shares</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 12, 2024, the Company effected a reverse stock split of its outstanding common stock and a reduction in the Company's authorized shares of common stock. As a result of the reverse stock split, each six outstanding shares of the Company’s common stock were combined into one outstanding share of common stock, without any change in par value. The common stock began trading on the Nasdaq Capital Market on a split-adjusted basis on April 15, 2024. No fractional shares were issued in connection with the reverse stock split and the Company will pay the fair value of such fractional shares in cash. As a result of the reduction in the Company's authorized shares of common stock, the Company's authorized shares went from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">142,857</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">47,619</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All share and per share amounts of the Company’s common stock, as well as stock options and restricted stock units (“RSUs”), included in the accompanying condensed consolidated financial statements have been retroactively adjusted to give effect to the reverse stock split for all periods presented, unless indicated otherwise. In addition, as a result of the reverse stock split, the Company reclassified an amount equal to the reduction in the par value of common stock to additional paid-in capital on its condensed consolidated balance sheets.</span></p>
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2411000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
21917000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9563000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-346662000
CY2024Q1 us-gaap Restructuring And Related Activities Description
RestructuringAndRelatedActivitiesDescription
The 2023 Restructuring Plan resulted in the reduction of the Company's global employees by 64 full-time employees during the second half of 2023, reducing its total headcount by approximately 37%. The 2023 Restructuring Plan was substantially complete in 2023
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0
CY2024Q1 mrin Company Capitalized
CompanyCapitalized
579000
CY2024Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
419000
CY2024Q1 mrin Subscription Contracts Term
SubscriptionContractsTerm
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
493000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
280000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
773000
CY2024Q1 mrin Unsatisfied Performance Obligation On Subscription Contract Term
UnsatisfiedPerformanceObligationOnSubscriptionContractTerm
P1Y
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4031000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4583000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4031000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4583000
CY2024Q1 mrin Deferred Costs To Fulfill Contracts Expected Period Of Benefit
DeferredCostsToFulfillContractsExpectedPeriodOfBenefit
P30M
CY2024Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53656000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53658000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50262000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50262000
CY2024Q1 mrin Accumulated Impairment Losse
AccumulatedImpairmentLosse
-3276000
CY2023Q4 mrin Accumulated Impairment Losse
AccumulatedImpairmentLosse
-3276000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
430000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
863000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
872000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
236000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
376000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
99000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
192000
CY2024Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
603000
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
636000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
19000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23000
CY2024Q1 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1820000
CY2023Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2099000
CY2023 mrin Wrote Off Credit Balance
WroteOffCreditBalance
443000
CY2023Q1 mrin Wrote Off Credit Balance
WroteOffCreditBalance
300000
CY2024Q1 mrin Wrote Off Credit Balance
WroteOffCreditBalance
0
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
413000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1032000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1613000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1912000
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
424000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
503000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1243000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
414000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1657000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
44000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1613000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1613000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
424000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
504000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
72000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
161000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
594000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2423000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5735000
CY2024Q1 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
368000
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2411000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5783000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3024000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3024000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2873000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2873000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.8
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.8
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.01
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
256000

Files In Submission

Name View Source Status
0000950170-24-052191-index-headers.html Edgar Link pending
0000950170-24-052191-index.html Edgar Link pending
0000950170-24-052191.txt Edgar Link pending
0000950170-24-052191-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrin-20240331.htm Edgar Link pending
mrin-20240331.xsd Edgar Link pending
mrin-20240331_htm.xml Edgar Link completed
mrin-ex31_1.htm Edgar Link pending
mrin-ex31_2.htm Edgar Link pending
mrin-ex32_1.htm Edgar Link pending
mrin-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable